Healthcare - Biotechnology - NASDAQ - US
$ 756.81
-3.28 %
$ 81.8 B
Market Cap
19.23
P/E
Price Target
Average
51.32%
Revenue Forecast
Estimate
8.84%
EBIT
Estimate
16.21%
Net Income
Estimate
16.29%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Regeneron Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for REGN of $1.15 K, with forecasts ranging from a low of $805 to a high of $1.3 K.
REGN Lowest Price Target
Wall Street Target
805 USD
6.37%
REGN Average Price Target
Wall Street Target
1.15 K USD
51.32%
REGN Highest Price Target
Wall Street Target
1.3 K USD
71.77%
REVENUE FORECAST
Revenue Forecast Chart REGN
EBIT FORECAST
EBIT Forecast Chart REGN
NET INCOME FORECAST
Net Income Chart REGN